Previous 10 | Next 10 |
Quoin Pharmaceuticals, Ltd. (QNRX) Q2 2022 Earnings Conference Call August 18, 2022 08:30 AM ET Company Participants Gordon Dunn - Chief Financial Officer Michael Myers - Chief Executive Officer Denise Carter - Chief Operating Officer and Director Conferenc...
Blue Water Vaccines ( BWV ) -30% . Eargo ( EAR ) -14% erasing yesterday's gain following FDA clearing over-the-counter hearing aid sales . Accelerate Diagnostics ( AXDX ) -13% on proposed public offering of common stock . Histogen ( HSTO ) ...
Quoin Pharmaceuticals press release ( NASDAQ: QNRX ): Q2 GAAP EPS of -$3.24. Quoin ended the second quarter with approximately $2.7 million in cash. Shares -5% PM. For further details see: Quoin Pharmaceuticals GAAP EPS of -$3.24
Initiates clinical trial evaluating lead product candidate, QRX003 for Netherton Syndrome Expands number of commercial partnerships to eight, covering 60 countries Signs Research Agreement to develop a product for the treatment of scleroderma Closes $16.8 million public ...
Gainers: Hill International ( HIL ) +61% . Laird Superfood ( LSF ) +25% Confirms Receipt of Unsolicited Offer. Quoin Pharmaceuticals ( QNRX ) +26% . Bed Bath & Beyond ( BBBY ) +24% jumps nearly 30% as meme stock rally rolls on . ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: oneinchpunch/Shutterstock.com We’ve got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about! Moving stocks this morning are reverse stock splits, ...
ASHBURN, Va., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its second quarter 2022 financial re...
ASHBURN, Va., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announced the closing of its previously announced p...
Gainers: CinCor Pharma CINC +66% . Karuna Therapeutics KRTX +61% . 23andMe ( ME ) +22% . Cerevel Therapeutics ( CERE ) +20% . Quoin Pharmaceuticals ( QNRX ) +16% . Losers: Reata Pharmaceuticals RETA -31% . uniQure QUR...
Bonso Electronics International ( BNSO ) +158% . MAGIC EMPIRE GLOBAL ( MEGL ) +101% . Karuna Therapeutics ( KRTX ) +50% as schizophrenia trial meets key goal. Bed Bath & Beyond ( BBBY ) +38% . Iveda Solutions ( IVDA ) +...
News, Short Squeeze, Breakout and More Instantly...
Quoin Pharmaceuticals Ltd. Company Name:
QNRX Stock Symbol:
NASDAQ Market:
ASHBURN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a clinical stage specialty p...
ASHBURN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release its first quart...
Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study with positive benefits observed across a number of clinical endpoints Eligibility age for enrollment into both studies has been lowered to fourteen...